Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 268-270

  Zycinska, K ^a   Wardyn, K A ^a   Zielonka, T M ^a   Krupa, R ^a   Lukas, W ^a  

^a Systemic Vasculitis Outpatient Clinic Warsaw   (Poland)

Author keywords

protein C receptor; thrombomodulin; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBOMODULIN; WEGENER GRANULOMATOSIS;

EID: 77955481163     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-268     Document Type: Article

References (15)

1. Pathogenesis of PR3-ANCA associated vasculitis. Kallenberg CG, J Autoimmun 2008 30 1-2 29 36 10.1016/j.jaut.2007.11.005 18162369
2. Wegener's Granulomatosis. Pagnoux C, Teixeira L, Presse Med 2007 36 5 860 887 10.1016/j.lpm.2007.02.015 17363211 (Pubitemid 46628738)
3. Thrombomodulin in the blood of patients with acute cerebral ischemia. Widerkiewicz K, Dzianott-Pabian D, Maslowska B, Kotschy M, Adv Clin Exp Med 2006 15 2 271 277 (Pubitemid 43833945)
4. Structure and function of thrombomodulin: a natural anticoagulant. Ditman WA, Majerus PW, Blood 1990 75 329 336 2153035 (Pubitemid 20035260)
5. Endotheliumspecific loss of murine thrombomoduline disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. Isermann B, Hendrikson SB, Zogg M, Wing M, Cummiskey M, Kisanuki YY, Yanagisawa M, Weiler H, J Clin Invest 2001 108 4 537 546 11518727 (Pubitemid 32777733)
6. Thrombomodulin gene variations and thromboembolic disease. Ohlin AK, Norlund L, Marlar RA, Thromb Haemost 1997 78 1 396 400 9198186 (Pubitemid 27289274)
7. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Van der Wouwer M, Collen D, Conway EM, Aterioscler Thromb Vasc Biol 2005 24 8 1374 1383 (Pubitemid 39050428)
8. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Salomaa V, Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK, Lancet 1999 353 1729 1734 10.1016/S0140-6736(98)09057-6 10347984 (Pubitemid 29240370)
9. Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis. Nienhuis HL, de Leeuw K, Smit AJ, Bijzet J, Stegeman CA, Kallenberg CG, Bijl M, J Rheumatol 2007 34 9 1875 1881 17659753 (Pubitemid 350067649)
10. Progress of treatment in ANCA-associated vasculitis. Jayne D, Nephrology 2009 14 1 42 48 10.1111/j.1440-1797.2009.01101.x 19335843
11. Vasculitis: lessons learned. Seo P, Curr Opin Rheumatol 2009 21 1 1 2 10.1097/BOR.0b013e32831e4250 19077712
12. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Boehme MWJ, Schmitt WH, Youinou P, Stremmal WR, Gross W, Am J Med 1996 101 387 393 10.1016/S0002-9343(96)00230-6 8873509 (Pubitemid 26392856)
13. Accelerated atherosclerosis in patients with Wegener's granulomatosis. De Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M, Ann Rheum Dis 2005 64 5 753 759 10.1136/ard.2004.029033 15374854 (Pubitemid 40559304)
14. What is the significance in routine care of c; ANCA/PR3ANCA in the absence of systemic vasculitis? A case series. Knight A, Ekbom A, Brandt L, Askling J, Clin Exp Rheumatol 2008 26 3 Suppl 49 53 S56 18799054
15. Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis. Boomsma MM, Stearns-Kurosawa DJ, Stegeman CA, Raschi E, Meroni PL, Kurosawa S, Tervaert JW, Clin Exp Immunol 2002 128 1 187 194 10.1046/j.1365-2249.2002.01803.x 12033194. (Pubitemid 34451198)